Bortezomib for desensitization of patients on a waiting list for deceased donor kidney transplant: experience in Mexico City.

Clinical transplants

Volumn , Issue , 2010, Pages 363-367

  Marino Vázquez, Lluvia A ^a   Leyva, Sergio ^b   Alberú, Josefina ^b   Morales Buenrostro, Luis E ^b  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; BORONIC ACID DERIVATIVE; BORTEZOMIB; HLA ANTIGEN; IMMUNOSUPPRESSIVE AGENT; PROTEASOME; PROTEINASE INHIBITOR; PYRAZINE DERIVATIVE;

ADULT; ARTICLE; BLOOD; CASE REPORT; DONOR; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; GRAFT SURVIVAL; HOSPITAL ADMISSION; HUMAN; IMMUNOLOGY; KIDNEY TRANSPLANTATION; MALE; METABOLISM; MEXICO; MIDDLE AGED; PATIENT SELECTION; PLASMAPHERESIS; TIME; TREATMENT OUTCOME;

ADULT; BORONIC ACIDS; DOWN-REGULATION; FEMALE; GRAFT SURVIVAL; HLA ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; MALE; MEXICO; MIDDLE AGED; PATIENT SELECTION; PLASMAPHERESIS; PROTEASE INHIBITORS; PROTEASOME ENDOPEPTIDASE COMPLEX; PYRAZINES; TIME FACTORS; TISSUE DONORS; TREATMENT OUTCOME; WAITING LISTS;

EID: 79960048982     PISSN: 08909016     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)